The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis

NCT ID: NCT04779502

Last Updated: 2021-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-12

Study Completion Date

2020-11-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the efficacy of commercially available oregano essential oil mouthwash in the reduction of oral halitosis was compared to chlorhexidine and distilled water and the results showed significant reduction of organoleptic tongue and floss scores and BANA test scores compared to placebo

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

the results showed that oregawash showed a comparable effect to chx in reducing oral halitosis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Halitosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oregano

oregawash mouthwash was used twice times daily for 7 days

Group Type EXPERIMENTAL

oregawash

Intervention Type OTHER

mouthwash containing oregano essential oil

placebo

distilled water was used twice times daily for 7 days

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

distilled water

chlorhexidine

Corsodyl with 0.2%CHX mouthwash was used twice times daily for 7 days

Group Type ACTIVE_COMPARATOR

corsodyl

Intervention Type OTHER

0.2% chlorhexidine mouthwash

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

oregawash

mouthwash containing oregano essential oil

Intervention Type OTHER

corsodyl

0.2% chlorhexidine mouthwash

Intervention Type OTHER

placebo

distilled water

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

chlorhexdine distilled water

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Organoleptic score was \>2 at baseline.
2. Participants between 18-23 years of age.
3. The subjects had no systemic disease and were not taking antibiotics or receiving other antimicrobial therapy.
4. The subjects did not receive the same time treatment for their halitosis.

Exclusion Criteria

1. Smokers, alcoholics and drug addicts.
2. Patients with periodontitis or pocket depth \>6 mm.
3. Patients taking drugs which induced xerostomia.
4. Subjects consuming spicy food: garlic or onions two days before examination.
5. Patients with orthodontic appliances or removable dentures.
6. pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

23 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MOHAMED SAEED M. ALI

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

MOHAMED SAEED M. ALI

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mohamed s albana, director

Role: PRINCIPAL_INVESTIGATOR

univeristy of baghdad

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Univeristy of Baghdad

Baghdad, Rasafa, Iraq

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iraq

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

131619

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.